APYP: AI 评分 50/100 — AI 分析 (4月 2026)

AppYea, Inc. is a digital health company specializing in sensor monitoring and software solutions for snoring and sleep apnea. Their product line includes smartphone applications and wristbands designed to detect and treat sleep-related breathing disorders.

Key Facts: Price: $0.01 AI Score: 50/100 Sector: Technology

公司概况

概要：

AppYea, Inc. develops and patents digital health solutions for sleep apnea and snoring, focusing on sensor-based monitoring and real-time detection. Their SleepX app and DreamIT wristband aim to provide accessible and convenient sleep disorder management, positioning them in the growing market for digital health technologies.

APYP是做什么的？

Founded in 2012 and based in Rehovot, Israel, AppYea, Inc. operates as a digital health company focused on designing, patenting, and producing sensor monitoring and software solutions for snoring and sleep apnea. The company's core product offerings include the SleepX App and DreamIT wristband. The SleepX App is a smartphone application that employs unique algorithms to monitor breathing and detect snoring events in real time. Complementing the app, the DreamIT wristband features various sensors and interfaces with the SleepX App to provide treatment for snoring. AppYea also offers SleepX PRO, an application designed to monitor breathing and detect sleep apnea incidents, and DreamIT PRO, a wristband that interfaces with the SleepX PRO app for sleep apnea treatment. AppYea aims to provide accessible and convenient solutions for individuals suffering from sleep-related breathing disorders, leveraging technology to improve sleep quality and overall health.

APYP的投资论点是什么？

AppYea, Inc. presents a focused investment opportunity within the digital health sector, specifically targeting the sleep apnea and snoring market. With a market capitalization of $0.01 billion and a gross margin of 15.8%, the company is positioned to capitalize on the increasing demand for accessible and convenient sleep monitoring and treatment solutions. Key value drivers include the continued development and refinement of their SleepX and DreamIT product lines, expansion into new markets, and potential partnerships with healthcare providers. The company's low beta of 0.11 suggests relatively low volatility compared to the broader market. However, investors should be aware of the risks associated with investing in OTC-listed companies and the competitive landscape of the digital health market.

APYP在哪个行业运营？

AppYea, Inc. operates within the rapidly expanding digital health market, specifically targeting sleep apnea and snoring solutions. The industry is characterized by increasing adoption of telehealth and remote patient monitoring technologies. The competitive landscape includes established medical device companies, as well as emerging digital health startups. AppYea's focus on sensor-based monitoring and smartphone integration positions it to capitalize on the growing demand for accessible and convenient sleep disorder management.

Software - Application

Technology

APYP有哪些增长机遇？

Expansion into New Markets: AppYea can expand its market reach beyond its current base by targeting new geographic regions and demographic segments. The global market for sleep apnea devices is projected to reach billions of dollars, offering significant growth potential for AppYea's SleepX and DreamIT products. Timeline: Ongoing.
Strategic Partnerships: Collaborating with healthcare providers, sleep clinics, and insurance companies can accelerate adoption of AppYea's solutions and increase market penetration. Partnerships can provide access to established distribution channels and patient networks. Timeline: Ongoing.
Product Innovation: Continuous innovation and development of new features for the SleepX and DreamIT product lines can enhance their value proposition and attract new customers. This includes incorporating advanced sensor technologies, AI-powered analytics, and personalized treatment plans. Timeline: Ongoing.
Direct-to-Consumer Marketing: Implementing targeted marketing campaigns to reach consumers directly through online channels, social media, and digital advertising can increase brand awareness and drive sales. This approach allows AppYea to bypass traditional healthcare channels and reach a wider audience. Timeline: Ongoing.
Integration with Telehealth Platforms: Integrating AppYea's solutions with telehealth platforms can provide remote monitoring and treatment options for patients with sleep apnea and snoring. This integration can enhance patient engagement and improve treatment outcomes. Timeline: Ongoing.

Market capitalization of $0.01 billion, reflecting its current valuation in the OTC market.
Gross margin of 15.8%, indicating the profitability of its products before operating expenses.
Free cash flow of $-0.00B, highlighting the need for careful cash management and potential future financing.
Beta of 0.11, suggesting lower volatility compared to the overall market.
Focus on the digital health market for sleep apnea and snoring, addressing a significant and growing health concern.

APYP提供哪些产品和服务？

Designs and patents sensor monitoring solutions.
Develops software for snoring and sleep apnea detection.
Produces the SleepX App for real-time snoring monitoring.
Manufactures the DreamIT wristband for snoring treatment.
Offers SleepX PRO for sleep apnea detection.
Provides DreamIT PRO for sleep apnea treatment.

APYP如何赚钱？

Develops and sells sensor-based monitoring devices (DreamIT wristband).
Offers smartphone applications (SleepX App, SleepX PRO) for sleep monitoring and treatment.
Generates revenue through direct sales to consumers.
Potential for future revenue through partnerships with healthcare providers and insurance companies.

Individuals suffering from snoring.
Individuals suffering from sleep apnea.
Healthcare providers seeking remote patient monitoring solutions.
Sleep clinics and sleep disorder centers.

Proprietary Algorithms: Unique algorithms for monitoring breathing and detecting snoring/sleep apnea events.
Patented Technology: Designs and patents for sensor monitoring and software solutions.
Integrated Solution: Combination of smartphone application and wearable device for comprehensive sleep monitoring and treatment.

什么因素可能推动APYP股价上涨？

Upcoming: Potential partnerships with healthcare providers and sleep clinics.
Ongoing: Continued development and refinement of SleepX and DreamIT product lines.
Ongoing: Expansion into new geographic markets.
Ongoing: Increased adoption of telehealth and remote patient monitoring.

APYP的主要风险是什么？

Potential: Competition from established medical device companies.
Potential: Technological obsolescence.
Ongoing: Limited financial resources.
Ongoing: OTC listing presents liquidity and regulatory challenges.
Potential: Regulatory changes in the healthcare industry.

APYP的核心优势是什么？

Proprietary technology for sleep monitoring and treatment.
Integrated solution combining app and wearable device.
Focus on the growing market for digital health solutions.
Low beta indicating lower volatility.

APYP的劣势是什么？

Limited financial resources.
Small number of employees.
Dependence on single product line.
OTC listing presents liquidity and regulatory challenges.

APYP有哪些机遇？

Expansion into new geographic markets.
Strategic partnerships with healthcare providers.
Development of new features and products.
Increased adoption of telehealth and remote patient monitoring.

APYP面临哪些威胁？

Competition from established medical device companies.
Technological obsolescence.
Regulatory changes in the healthcare industry.
Economic downturn affecting consumer spending.

Key Metrics

Price: $0.01 (+20.67%)
Market Cap: $9.0M
MoonshotScore: 50/100

Company Profile

CEO: Yakir Abady
Headquarters: Gan Yavne, IL
Employees: 9
Founded: 2014

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does AppYea, Inc. do?

AppYea, Inc. is a digital health company that specializes in developing and marketing sensor-based monitoring and software solutions for individuals suffering from snoring and sleep apnea. The company's core products include the SleepX App and DreamIT wristband, which work together to monitor breathing patterns, detect sleep disturbances, and provide real-time feedback. By leveraging technology to address sleep-related breathing disorders, AppYea aims to improve sleep quality and overall health for its customers.

What do analysts say about APYP stock?

As of 2026-03-15, there is limited analyst coverage available for APYP stock due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and due diligence before investing in APYP. Key valuation metrics to consider include the company's gross margin of 15.8% and its free cash flow of $-0.00B. Growth considerations include the company's potential to expand into new markets and develop new products.

What are the main risks for APYP?

Investing in AppYea, Inc. carries several risks, including limited liquidity due to its OTC listing, competition from established medical device companies, and the potential for technological obsolescence. The company's small size and limited financial resources also present challenges. Additionally, regulatory changes in the healthcare industry could impact the company's business model and profitability. Investors should carefully consider these risks before investing in APYP.